Alnylam Pharmaceuticals Inc
Veridion Score
Composite trend over time
Why is ALNY moving today?
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for ALNY.
ALNY insider activity
Alnylam Pharmaceuticals Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$19.6M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I | Insider | sell | $302.65 | 17 | 1,582 | $5K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I | Insider | sell | $300.72 | 495 | 1,599 | $149K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I | Insider | sell | $299.87 | 1,222 | 2,094 | $366K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I | Insider | sell | $298.91 | 1,175 | 3,316 | $351K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | PYOTT DAVID E I | Insider | sell | $297.71 | 921 | 4,491 | $274K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 146 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moALNY contract awards, year to date.
Public federal awards linked to this ticker.
ALNY lobbying filings, year to date.
Registered lobbying filings matched to Alnylam Pharmaceuticals Inc.
ALNYLAM PHARMACEUTICALS, INC.
ALNYLAM PHARMACEUTICALS, INC.
LMH STRATEGIC SOLUTIONS